Actualités Ampio Pharmaceuticals Inc (CE) - AMPE | Actions OTCMarkets

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Current Report Filing (8-k)

l UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...

Ampio Pharmaceuticals' Vyrix Files Registration Statement for Proposed Initial Public Offering

Ampio Pharmaceuticals' Vyrix Files Registration Statement for Proposed Initial Public Offering PR Newswire GREENWOOD VILLAGE, Colo., April 21...

(25)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C...

- Securities Registration (section 12(b)) (8-A12B)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-A FOR...

Ampio Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Capital Market

Ampio Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Capital Market PR Newswire GREENWOOD VILLAGE, Colo., May 17, 2011 GREENWOOD...

- Quarterly Report (10-Q)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ...

- Securities Registration Statement (S-1)

Table of Contents As filed with the Securities and Exchange Commission on April 19, 2011...

- Current report filing (8-K)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant...

Ampio Pharmaceuticals, Inc. Announces Final Closing of Private Placement and Filing of Resale Registration Statement

Ampio Pharmaceuticals, Inc. Announces Final Closing of Private Placement and Filing of Resale Registration Statement PR Newswire GREENWOOD...

- Current report filing (8-K)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant...

- Current report filing (8-K)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Ampio Pharmaceuticals Inc (CE) (AMPE)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

AMPE Actualités

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Current Report Filing (8-k)

Current Report Filing (8-k)

Ampio Pharmaceuticals' Vyrix Files Registration Statement for Proposed Initial Public Offering

(25)

- Securities Registration (section 12(b)) (8-A12B)

Ampio Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Capital Market

- Quarterly Report (10-Q)

- Securities Registration Statement (S-1)

- Current report filing (8-K)

Ampio Pharmaceuticals, Inc. Announces Final Closing of Private Placement and Filing of Resale Registration Statement

- Current report filing (8-K)

- Current report filing (8-K)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Ampio Pharmaceuticals Inc (CE) (AMPE) Actualités

Ampio Pharmaceuticals Inc (CE) (AMPE)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

AMPE Actualités

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Current Report Filing (8-k)

Current Report Filing (8-k)

Ampio Pharmaceuticals' Vyrix Files Registration Statement for Proposed Initial Public Offering

(25)

- Securities Registration (section 12(b)) (8-A12B)

Ampio Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Capital Market

- Quarterly Report (10-Q)

- Securities Registration Statement (S-1)

- Current report filing (8-K)

Ampio Pharmaceuticals, Inc. Announces Final Closing of Private Placement and Filing of Resale Registration Statement

- Current report filing (8-K)

- Current report filing (8-K)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application